FDA Inspection 1001534 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3007895922

The FDA completed an inspection of Biomat USA, Inc. on Nov 17, 2016 in Jacksonville, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 17, 2016
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Jacksonville, FL (United States)

Citations

IDCFRDescription
1809721 CFR 630.10(h)Ineligible Donor
924321 CFR 630.40(a)Notification
9821 CFR 606.100(c)Thorough investigations